Results 141 to 150 of about 7,978,447 (307)
STING/Type I Interferon Pathway Activation Confers Multimodal Therapeutic Benefits in Osteomyelitis
STING/type I interferon signaling counteracts osteomyelitis through coordinated control of pain, bone destruction, and abscess formation. It inhibits pathogen‐induced nociceptor activation, restrains osteoclast‐mediated bone resorption, and suppresses IL‐1β‐driven neutrophil recruitment.
Yang Chen +19 more
wiley +1 more source
Risk of Major Adverse Cardiovascular Event Following Incident Hospitalization for Acute Gout: A Western Australian Population-Level Linked Data Study. [PDF]
Lopez D +7 more
europepmc +1 more source
Major adverse cardiovascular events of the patients with CAD followed-up.
Major adverse cardiovascular events of the patients with CAD followed-up.
Naifeng Liu (311606) +5 more
core +1 more source
PCSK9 upregulation in cerebrovascular endothelial cells and microglia destabilizes the Aβ transporter LRP1, while TRIB3‐associated autophagy blockade further limits intracellular Aβ degradation. A RAP‐modified tea‐polyphenol nanoparticle co‐delivers siPCSK9 and siTRIB3 to restore LRP1‐mediated Aβ efflux and autophagy‐dependent degradation, reducing Aβ ...
Jie Miao +8 more
wiley +1 more source
Background Aortic stenosis (AS) is a representative geriatric disease, and there is an anticipated rise in the number of patients requiring noncardiac surgeries in patients with AS.
Minjung Bak +9 more
doaj +1 more source
Orally administered recombinant human type III collagen protects the gastric mucosa from ethanol‐induced injury by coordinating redox homeostasis, epithelial barrier repair, and arachidonic acid–prostaglandin metabolism. Gastric digestion releases the pentapeptide GPAEF, which interacts with the Pla2g4a promoter G‐quadruplex in a structure‐dependent ...
Xinyue Lan +14 more
wiley +1 more source
Background Carpal tunnel syndrome (CTS) has been recognized as a potential early manifestation of systemic amyloidosis; however, its prognostic implications for cardiovascular and renal outcomes remain unclear.
Wei‐Ting Wang +2 more
doaj +1 more source
Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials. [PDF]
Deng CJ +9 more
europepmc +1 more source
Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population
BackgroundCardiovascular disease (CVD) remains a leading cause of morbidity and mortality globally, with metabolic syndrome (MS) being a significant contributor to major adverse cardiovascular events (MACE). While the relationship between MS and CVD is well established, limited studies have focused on elderly populations, particularly in the context of
Shailendra Kumar Karn +8 more
openaire +3 more sources

